EID Parry Schedules Investor Call on May 27
E.I.D.-Parry (India) Limited has scheduled a conference call for May 27, 2026, to review its audited financial results for the quarter and year ended March 31, 2026. The session, led by CEO Mr. Muthiah Murugappan, allows investors and analysts to participate via specific dial-in numbers. No unpublished price sensitive information will be disclosed during the interaction.

*this image is generated using AI for illustrative purposes only.
E.I.D.-Parry (India) Limited has announced an Analyst and Investor Call scheduled for Wednesday, May 27, 2026, to discuss the audited financial results for the quarter and year ended March 31, 2026. The meeting will be held via conference call at 11:00 hrs IST and is open to all investors, financial institutions, and analysts.
Conference Call Details
The interaction is pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has clarified that no unpublished price sensitive information will be shared during the call. The management team, including Mr. Muthiah Murugappan, Whole Time Director & CEO, will lead the discussion.
| Parameter | Details |
|---|---|
| Date | Wednesday, May 27, 2026 |
| Time | 11:00 hrs (IST) |
| Mode | Conference Call |
| Participants | Open to investors and analysts |
| Access Numbers | +91 22 6280 1384, +91 22 7115 8285 |
International Dial-in Timings
International participants can join the call according to the following schedule:
- Hong Kong: 13:30 (HKT)
- Singapore: 13:00 (SGT)
- UK: 06:30 (BST)
- USA: 01:30 (EDT)
Participants are requested to dial in at least 5-10 minutes prior to the scheduled start time. The intimation was signed by Biswa Mohan Rath, Company Secretary, on May 18, 2026.
Historical Stock Returns for EID Parry
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.21% | -1.69% | -8.62% | -23.28% | -19.55% | +85.03% |
How might E.I.D.-Parry's FY26 annual results reflect the impact of fluctuating sugar prices and monsoon variability on its core agribusiness segments?
Will the management commentary during the May 27 investor call provide any guidance on E.I.D.-Parry's expansion plans in the nutraceuticals or bio-pesticides segments for FY27?
How could E.I.D.-Parry's consolidated results be influenced by the financial performance of its subsidiary Coromandel International amid evolving agrochemical market dynamics?


































